Opinions

Infectious diseases 14 October 2024

Mpox: a resurging global threat

For the second time in three years, mpox has been declared a global health emergency — the highest level of alert given by the World Health Organization (WHO). Such a declaration demands continued monitoring, surveillance and response to ameliorate further transmission.

Lead image 2024 10 10 T153911 783
Medical innovation 8 October 2024

Biodesign: a clinical training framework for medical technology innovation

Clinicians play a critical role in medical technology innovation; however, structured training in this discipline is lacking in Australia. We propose that formal education, using well validated methodologies, should be incorporated into clinical training at both undergraduate and postgraduate levels.

Lead image 2024 10 03 T110538 409
Health policy 30 September 2024

The proposed sale of Vectura by Philip Morris International: what it means for Australia’s respiratory health

The proposed sale of Vectura by Philip Morris International is a significant moment in the fight against Big Tobacco’s influence on health care. The Thoracic Society of Australia and New Zealand explores the implications of the sale and calls for continued vigilance to keep tobacco and vaping companies out of the pharmaceutical sector.

Lead image 2024 09 26 T100118 918